Literature DB >> 1327537

All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs.

B Durand1, M Saunders, P Leroy, M Leid, P Chambon.   

Abstract

Two cooperating retinoic acid response elements (RAREs) in the cellular retinoic acid-binding protein II (CRABPII) gene mediate differential transcriptional transactivation by retinoic acid receptors (RARs) and retinoid X receptors (RXRs) in P19 embryonal carcinoma cells. RARE1 and RARE2 are direct repeats (DR) of two motifs separated by 2 bp (DR2) and 1 bp (DR1), respectively, and bind RAR-RXR heterodimers more efficiently than homodimers. Using all-trans and 9-cis RA, which differentially activate RARs and RXRs, and RAR and RXR dominant-negative mutants, RAR-RXR heterodimers bound to RARE1 and RARE2 are shown to be responsible for CRABPII promoter transactivation, arguing against a unique DR spacing specifying recognition by RARs. Within heterodimers, RAR and RXR independently and differentially transactivate, depending on the specific RARE. Consistent with these results, 9-cis RA increases CRABPII mRNA levels more efficiently than all-trans RA. In contrast, all-trans and 9-cis RA have identical effects on induction of RAR beta 2 transcripts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327537     DOI: 10.1016/0092-8674(92)90267-g

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  102 in total

1.  Retinoid receptors trigger neuritogenesis in retinal degenerations.

Authors:  Yanhua Lin; Bryan W Jones; Aihua Liu; James F Tucker; Kevin Rapp; Ling Luo; Wolfgang Baehr; Paul S Bernstein; Carl B Watt; Jia-Hui Yang; Marguerite V Shaw; Robert E Marc
Journal:  FASEB J       Date:  2011-09-22       Impact factor: 5.191

2.  PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.

Authors:  Igor Gurevich; Carmen Zhang; Priscilla C Encarnacao; Charles P Struzynski; Sarah E Livings; Brian J Aneskievich
Journal:  Biochim Biophys Acta       Date:  2011-10-07

3.  The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease.

Authors:  Ian D Welch; Matthew F Cowan; Frank Beier; Tully M Underhill
Journal:  Arthritis Res Ther       Date:  2009-01-28       Impact factor: 5.156

4.  Expression and regulation of nuclear retinoic acid receptors in human lymphoid cells.

Authors:  Mark Ballow; Xiaochuan Wang; Shunan Xiang; Cheryl Allen
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

5.  Expression of cellular retinol- and cellular retinoic acid-binding proteins in the rat cervical epithelium is regulated by endocrine stimuli during normal squamous metaplasia.

Authors:  L Tannous-Khuri; P Hillemanns; N Rajan; T C Wright; D A Talmage
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

6.  Two silencing sub-domains of v-erbA synergize with each other, but not with RXR.

Authors:  B Martin; R Renkawitz; M Muller
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

7.  The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.

Authors:  H W Chen; M L Privalsky
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

8.  Direct repeats bind the EcR/USP receptor and mediate ecdysteroid responses in Drosophila melanogaster.

Authors:  C Antoniewski; B Mugat; F Delbac; J A Lepesant
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor.

Authors:  X K Zhang; G Salbert; M O Lee; M Pfahl
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.

Authors:  H Chiba; M Muramatsu; A Nomoto; H Kato
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.